Fatmi; Aqeel A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fatmi; Aqeel A..The latest application filed is for "liquisoft capsules".
Company Profile
6.39.51
- Fatmi; Aqeel A. - High Point NC
- Fatmi; Aqeel A - High Point NC
- Fatmi; Aqeel A. - Greensboro NC
Patent Activity
| Patent | Date |
|---|---|
| Liquisoft Capsules App 20220211616 - Zhao; YinYan ; et al. | 2022-07-07 |
| Liquid Dosage Forms Of Sodium Naproxen App 20210338616 - CHIDAMBARAM; Nachiappan ; et al. | 2021-11-04 |
| Liquid dosage forms of sodium naproxen Grant 11,090,280 - Chidambaram , et al. August 17, 2 | 2021-08-17 |
| Fumarate Ester Dosage Forms App 20210161852 - Vaughn; Jason M. ; et al. | 2021-06-03 |
| Fumarate ester dosage forms Grant 10,945,985 - Vaughn , et al. March 16, 2 | 2021-03-16 |
| Fumarate ester pharmaceutical compositions Grant 10,918,616 - Dyakonov , et al. February 16, 2 | 2021-02-16 |
| Fumarate esters Grant 10,918,615 - Vaughn , et al. February 16, 2 | 2021-02-16 |
| Fumarate ester pharmaceutical compositions Grant 10,918,617 - Dyakonov , et al. February 16, 2 | 2021-02-16 |
| Abuse-deterrent Compositions App 20200368169 - Gosangari; Saujanya ; et al. | 2020-11-26 |
| Abuse-deterrent opioids Grant 10,772,842 - Gosangari , et al. Sept | 2020-09-15 |
| Liquisoft Capsules App 20200121595 - Zhao; YinYan ; et al. | 2020-04-23 |
| Liquisoft capsules Grant 10,555,901 - Zhao , et al. Feb | 2020-02-11 |
| Enteric soft capsules comprising polyunsaturated fatty acids Grant 10,188,624 - Zhang , et al. Ja | 2019-01-29 |
| Enhanced bioavailability of polyunsaturated fatty acids Grant 10,188,623 - Zhang , et al. Ja | 2019-01-29 |
| Compositions for colonic delivery of drugs Grant 10,182,993 - Yang , et al. Ja | 2019-01-22 |
| Abuse-deterrent controlled release formulations Grant 10,182,992 - Vamvakas , et al. Ja | 2019-01-22 |
| Fumarate Ester Pharmaceutical Compositions App 20190015374 - Dyakonov; Tatyana ; et al. | 2019-01-17 |
| Fumarate Esters App 20190015372 - Vaughn; Jason M. ; et al. | 2019-01-17 |
| Fumarate Ester Dosage Forms App 20190015373 - Vaughn; Jason M. ; et al. | 2019-01-17 |
| Fumarate Ester Pharmaceutical Compositions App 20190008818 - Dyakonov; Tatyana ; et al. | 2019-01-10 |
| Fumarate ester dosage forms Grant 10,105,335 - Vaughn , et al. October 23, 2 | 2018-10-23 |
| Fumarate ester pharmaceutical compositions Grant 10,105,337 - Dyakonov , et al. October 23, 2 | 2018-10-23 |
| Fumarate ester pharmaceutical compositions Grant 10,105,336 - Dyakonov , et al. October 23, 2 | 2018-10-23 |
| Liquid Dosage Forms Of Sodium Naproxen App 20180296512 - Chidambaram; Nachiappan ; et al. | 2018-10-18 |
| Fumarate esters Grant 10,098,863 - Vaughn , et al. October 16, 2 | 2018-10-16 |
| Liquid dosage forms of sodium naproxen Grant 10,028,925 - Chidambaram , et al. July 24, 2 | 2018-07-24 |
| Liquid dosage forms of sodium naproxen Grant 10,022,344 - Chidambaram , et al. July 17, 2 | 2018-07-17 |
| Enhanced Bioavailability of Polyunsaturated Fatty Acids App 20180169050 - ZHANG; Peijin ; et al. | 2018-06-21 |
| Enteric Soft Capsules Comprising Polyunsaturated Fatty Acids App 20180169051 - ZHANG; Peijin ; et al. | 2018-06-21 |
| Immediate Release Soluble Ibuprofen Compositions App 20180071221 - ROBERTS; Tanesha ; et al. | 2018-03-15 |
| Liquid Dosage Forms Of Sodium Naproxen App 20180071236 - Chidambaram; Nachiappan ; et al. | 2018-03-15 |
| Fumarate Ester Dosage Forms App 20180055804 - Vaughn; Jason M. ; et al. | 2018-03-01 |
| Fumarate Ester Pharmaceutical Compositions App 20180055806 - Dyakonov; Tatyana ; et al. | 2018-03-01 |
| Fumarate Ester Pharmaceutical Compositions App 20180055805 - Dyakonov; Tatyana ; et al. | 2018-03-01 |
| Liquisoft Capsules App 20180049979 - Zhao; YinYan ; et al. | 2018-02-22 |
| Enhanced bioavailability of polyunsaturated fatty acids Grant 9,895,333 - Zhang , et al. February 20, 2 | 2018-02-20 |
| Enteric soft capsules comprising polyunsaturated fatty acids Grant 9,895,332 - Zhang , et al. February 20, 2 | 2018-02-20 |
| Liquisoft capsules Grant 9,867,779 - Zhao , et al. January 16, 2 | 2018-01-16 |
| Controlled Release Preparations App 20180008548 - Hassan; EmadEldin M. ; et al. | 2018-01-11 |
| Fumarate Esters App 20170348270 - Vaughn; Jason M. ; et al. | 2017-12-07 |
| Fumarate ester pharmaceutical compositions Grant 9,820,960 - Dyakonov , et al. November 21, 2 | 2017-11-21 |
| Fumarate ester dosage forms Grant 9,820,961 - Vaughn , et al. November 21, 2 | 2017-11-21 |
| Fumarate ester pharmaceutical compositions Grant 9,814,691 - Dyakonov , et al. November 14, 2 | 2017-11-14 |
| Fumarate ester dosage forms Grant 9,814,692 - Vaughn , et al. November 14, 2 | 2017-11-14 |
| Liquid Dosage Forms Of Sodium Naproxen App 20170296495 - Chidambaram; Nachiappan ; et al. | 2017-10-19 |
| Fumarate Ester Dosage Forms App 20170231942 - Vaughn; Jason M. ; et al. | 2017-08-17 |
| Liquid dosage forms of sodium naproxen Grant 9,693,979 - Chidambaram , et al. July 4, 2 | 2017-07-04 |
| Fumarate ester dosage forms Grant 9,636,318 - Vaughn , et al. May 2, 2 | 2017-05-02 |
| Fumarate ester dosage forms Grant 9,636,319 - Vaughn , et al. May 2, 2 | 2017-05-02 |
| Fumarate Ester Dosage Forms App 20170100361 - Vaughn; Jason M. ; et al. | 2017-04-13 |
| Fumarate Ester Dosage Forms App 20170100362 - Vaughn; Jason M. ; et al. | 2017-04-13 |
| Fumarate Ester Pharmaceutical Compositions App 20170100360 - Dyakonov; Tatyana ; et al. | 2017-04-13 |
| Fumarate Ester Pharmaceutical Compositions App 20170071891 - Dyakonov; Tatyana ; et al. | 2017-03-16 |
| Fumarate Ester Dosage Forms App 20170056360 - Vaughn; Jason M. ; et al. | 2017-03-02 |
| Fumarate Ester Dosage Forms App 20170056359 - Vaughn; Jason M. ; et al. | 2017-03-02 |
| Methods for enhancing the release and absorption of water insoluble active agents Grant 9,566,274 - Fatmi , et al. February 14, 2 | 2017-02-14 |
| Fumarate ester dosage forms Grant 9,566,259 - Vaughn , et al. February 14, 2 | 2017-02-14 |
| Fumarate ester pharmaceutical compositions Grant 9,517,209 - Dyakonov , et al. December 13, 2 | 2016-12-13 |
| Fumarate ester pharmaceutical compositions Grant 9,511,043 - Dyakonov , et al. December 6, 2 | 2016-12-06 |
| Pharmaceutical compositions for poorly soluble active ingredients Grant 9,504,656 - Vamvakas , et al. November 29, 2 | 2016-11-29 |
| Compositions For Colonic Delivery Of Drugs App 20160287525 - Yang; Chue Hue ; et al. | 2016-10-06 |
| Liquisoft Capsules App 20160279056 - Zhao; Yinyan ; et al. | 2016-09-29 |
| Liquid Dosage Forms Of Sodium Naproxen App 20160263063 - Chidambaram; Nachiappan ; et al. | 2016-09-15 |
| Enteric soft capsules Grant 9,433,585 - Hassan , et al. September 6, 2 | 2016-09-06 |
| Controlled Release Fumarate Esters App 20160199336 - Dyakonov; Tatyana ; et al. | 2016-07-14 |
| Abuse-deterrent Opioids App 20160199368 - Gosangari; Saujanya ; et al. | 2016-07-14 |
| Controlled Release Fumarate Esters App 20160199335 - Dyakonov; Tatyana ; et al. | 2016-07-14 |
| Controlled release fumarate esters Grant 9,326,947 - Dyakonov , et al. May 3, 2 | 2016-05-03 |
| Controlled release fumarate esters Grant 9,326,965 - Dyakonov , et al. May 3, 2 | 2016-05-03 |
| Enteric Soft Capsules App 20160106682 - HASSAN; EmadEldin M. ; et al. | 2016-04-21 |
| Controlled Release Enteric Soft Capsules Of Fumarate Esters App 20160101059 - Dyakonov; Tatyana ; et al. | 2016-04-14 |
| Enteric soft capsules Grant 9,254,270 - Hassan , et al. February 9, 2 | 2016-02-09 |
| Enhanced Bioavailability Of Polyunsaturated Fatty Acids App 20160000740 - Zhang; Peijin ; et al. | 2016-01-07 |
| Liquid-filled Immediate Release Soft Gelatin Capsules App 20150366813 - Thakur; Rishi ; et al. | 2015-12-24 |
| Enteric Soft Capsules App 20150352054 - Hassan; Emadeldin M. ; et al. | 2015-12-10 |
| Abuse-deterrent Controlled Release Formulations App 20150283087 - Vamvakas; George ; et al. | 2015-10-08 |
| Controlled Release Enteric Soft Capsules Of Fumarate Esters App 20150246016 - Dyakonov; Tatyana ; et al. | 2015-09-03 |
| Enteric Soft Capsules Comprising Polyunsaturated Fatty Acids App 20150118298 - Zhang; Peijin ; et al. | 2015-04-30 |
| Pharmaceutical Compositions For Poorly Soluble Active Ingredients App 20150108033 - Vamvakas; George ; et al. | 2015-04-23 |
| Controlled Release Preparations App 20150010623 - Hassan; EmadEldin M. ; et al. | 2015-01-08 |
| Enteric Soft Capsules App 20140348879 - Hassan; EmadEldin M. ; et al. | 2014-11-27 |
| Enteric Soft Capsules App 20140154311 - Hassan; Emadeldin M. ; et al. | 2014-06-05 |
| Enteric composition for the manufacture of soft capsule wall Grant 8,685,445 - Hassan , et al. April 1, 2 | 2014-04-01 |
| Stable solutions of orlistat for pharmaceutical dosage forms Grant 8,309,107 - Liu , et al. November 13, 2 | 2012-11-13 |
| Stable Solutions Of Orlistat For Pharmaceutical Dosage Forms App 20100087520 - Liu; Zhi ; et al. | 2010-04-08 |
| Enteric composition for the manufacture of soft capsule wall App 20060165778 - Hassan; Emadeldin M. ; et al. | 2006-07-27 |
| Formulations of bisphosphonate drugs with improved bioavailability App 20060134190 - Kim; Tae Kyoung ; et al. | 2006-06-22 |
| Controlled Release Preparation App 20060115527 - Hassan; Emadeldin M. ; et al. | 2006-06-01 |
| Non-blooming gelatin and non-gelatin formulations App 20060088590 - Sukuru; Karunakar ; et al. | 2006-04-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 